XTX Topco’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$116K Buy
+27,646
New +$107K ﹤0.01% 3479
2026
Q1
Sell
-43,904
Closed -$148K 4074
2025
Q4
$148K Buy
43,904
+32,657
+290% +$84.8K ﹤0.01% 2508
2025
Q3
$14.7K Buy
+11,247
New +$11.6K ﹤0.01% 2380
2025
Q2
Sell
-552,613
Closed -$812K 2757
2025
Q1
$812K Buy
552,613
+506,732
+1,104% +$1.21M 0.04% 682
2024
Q4
$203K Buy
+45,881
New +$186K 0.02% 1547
2024
Q2
Sell
-55,658
Closed -$485K 2148
2024
Q1
$485K Buy
55,658
+9,213
+20% +$112K 0.07% 502
2023
Q4
$531K Buy
46,445
+30,432
+190% +$301K 0.12% 222
2023
Q3
$154K Sell
16,013
-34,638
-68% -$339K 0.03% 1098
2023
Q2
$539K Buy
+50,651
New +$544K 0.1% 324
2022
Q3
Sell
-34,810
Closed -$401K 1239
2022
Q2
$401K Buy
+34,810
New +$410K 0.16% 175
2021
Q2
Sell
-13,698
Closed -$153K 946
2021
Q1
$153K Buy
+13,698
New +$145K 0.07% 528

Other funds holding IRWD

XTX Topco's IRWD Position: Q2 2026 in Review

XTX Topco opened a new position in Ironwood Pharmaceuticals (IRWD) in Q2 2026: 27,646 shares worth $116K. The stake represents ﹤0.01% of the portfolio and ranks #3479 among its holdings. This is a return to the name: XTX Topco previously reported a position in IRWD as recently as Q4 2025.

XTX Topco first reported a position in IRWD in Q1 2021 and has held it in 11 quarters since. The position peaked at $812K in Q1 2025. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • XTX Topco held 27,646 shares of Ironwood Pharmaceuticals worth $116K as of Q2 2026.
  • Ironwood Pharmaceuticals was a new XTX Topco position in Q2 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3479 holding.
  • XTX Topco first reported a position in Ironwood Pharmaceuticals in Q1 2021 and has held it in 11 quarters since.
  • XTX Topco's Ironwood Pharmaceuticals position peaked at $812K in Q1 2025.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.